GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
94 hedge funds and large institutions have $863M invested in G1 Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 43 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
+1
Holders Change %
+1.08%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
18
Increased
43
Reduced
21
Closed
14
Calls
$401K
Puts
$245K
Net Calls
+$156K
Net Calls Change
+$151K
Top Buyers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
$20.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
$159M |
| 3 |
BlackRock
New York
|
$75.7M |
| 4 |
JPMorgan Chase & Co
New York
|
$44.4M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
$8.98M |
Top Sellers
| 1 |
Bank of New York Mellon
New York
|
$4.14M |
| 2 |
Morgan Stanley
New York
|
$430K |
| 3 |
Citadel Advisors
Miami,
Florida
|
$708K |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
$9.53M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$421K |
